Login / Signup

Modulation of inflammatory response after myocardial infarction: one explanation for the cardiovascular benefit of empagliflozin in the EMMY trial?

Antonin TrimailleBenjamin MarchandotOlivier Morel
Published in: European heart journal (2023)
Keyphrases
  • inflammatory response
  • lipopolysaccharide induced
  • phase iii
  • study protocol
  • lps induced
  • phase ii
  • toll like receptor
  • clinical trial
  • open label
  • randomized controlled trial
  • double blind